StockGuru Blog: The Immune Response Corporation Sees Valuation Pressure Relieved with Warrant Expiration Imminent
IMNR - The Immune Response Corporation should experience a relief of recent valuation depression this week. The overhang of 600MM warrants @ $0.02 per share is virtually gone. The warrants expire on 8/7/06, and with 3-day settlement warrant-holders are no longer able to sell and exercise their warrants. This should relieve enormous pressure from the stock. The financing has been absorbed. The next set of warrants do not become exercisable until October 16 through November 30. IMNR stock closed at $0.24 per share, ten times where it is currently trading, on March 7, 2006, the day the financing was announced.…